Five Digits Test: a quick inhibition test for adults with ADHD or autism
Official title: Five Digits Test - Validation of a Neuropsychological Test of Inhibition for Patients With Neuropsychiatric Conditions
Run by Umeå University · NCT07531914 · Data updated 2026-11-12
This project will test whether the Five Digits Test is a quick, language-light way to measure inhibition in adults with ADHD or autism.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Umeå University Academic / other |
| Locations | 1 site (Umeå) |
| Status | Recruiting |
| Started | January 21, 2026 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | April 15, 2026 |
| Trial ID | NCT07531914 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) diagnosed with or under evaluation for ADHD or autism who can read Swedish well enough to consent and complete testing and are able to undergo neuropsychological assessment are ideal candidates.
✕Probably not a fit
People with active alcohol or drug addiction, those taking sedatives that affect testing, non-Swedish speakers who cannot consent, or individuals unable to complete neuropsychological testing are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a cross-sectional validation comparing the Five Digits Test (FDT) to the standard Color-Word Interference Test (CWIT) and the BRIEF-A questionnaire in adults with diagnosed or suspected ADHD or autism and healthy controls. Participants complete demographic and health questions, then are randomly assigned to take the FDT or CWIT first to control for order and learning effects. Researchers will use correlation coefficients to examine convergent validity and perform regressions and group comparisons (t-tests/ANCOVAs) to adjust for background variables and test differences. The protocol excludes people with active substance addiction, insufficient Swedish language to consent, current sedative use, or inability to complete neuropsychological testing.
Why it matters
Potential benefit: If successful, the FDT could give clinicians a simpler, lower-language-demand tool to measure inhibition, helpful for patients with limited reading or language skills.
How similar studies have gone: The CWIT and BRIEF-A are well-established measures of inhibition and executive function, while the FDT is a newer, less-tested tool with limited prior validation data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age 18 and above * Diagnosed with a ADHD or Autism, alternatively under examination these diagnoses Exclusion Criteria: * Addiction of alcohol or other substances * Not speaker of Swedish to such extent that cannot read or comprehend the informed consent forms * On sedatives, such as sleep or pain medication * Not being able to participate in a neuropsychological examination, or to give informed consent
Where it's running
-
Umeå University, Umeå University Hospital
Umeå, Sweden Recruiting
Study contacts
- Study coordinator: Nils Berginström, PhD
- Email: nils.berginstrom@umu.se
- Phone: +46907868864
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Combined training to improve thinking skills and emotional control for children with ADHD, dyslexia, or autism
This program will test whether a combined training that targets both 'cool' thinking skills (like working memory) and 'hot' emotion-related control can help primary-school children aged 6–11 with ADHD, dyslexia (SpLD), or autism.
-
Spanish-language Unstuck and On Target program for children with autism or ADHD
This program will test whether a Spanish-language version of Unstuck and On Target helps Spanish-speaking caregivers and their 8–11-year-old children with autism and/or ADHD improve executive skills and reduce caregiver strain.
-
Footsteps app to improve behavioral data collection, supervision, and student outcomes
This test will see if a smartphone app called Footsteps helps school aides collect better behavior data and improves outcomes for students aged 3–17 who receive one-to-one support.
-
Exploring how early life experiences affect brain and behavior
This study looks at how early life experiences like adoption and trauma affect brain development and behavior in young adults to help identify those at risk for mental health issues later on.
-
Comparing Sertraline and Placebo for Treating Anxiety in Children with Neurodevelopmental Disorders
This study is testing if the medication sertraline can help reduce anxiety in children and teens aged 8-17 with neurodevelopmental disorders like autism and Fragile X syndrome compared to a placebo.
-
Biomarkers that predict medication-related side effects in children with ADHD
This study tests whether combined brain, cognitive, and metabolite markers can predict side effects from methylphenidate in kids with ADHD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.